LARONDA LANG: Open Payments
NPI 1154850683 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,044 in 247 payments from 34 companies in 2025. Trend: 2023 $4,091 · 2024 $5,158 · 2025 $5,044
Food & beverage: $5,044
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 20 | $710 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $367 |
| ABBVIE INC. | 20 | $356 |
| PFIZER INC. | 16 | $340 |
| Corcept Therapeutics | 16 | $339 |
| Otsuka America Pharmaceutical, Inc. | 16 | $266 |
| Novo Nordisk Inc | 12 | $246 |
| Indivior Inc. | 11 | $225 |
| UCB, Inc. | 8 | $224 |
| Kowa Pharmaceuticals America, Inc. | 33 | $211 |
Products named: Auvelity, CAPLYTA, REXULTI, Korlym, NURTEC ODT, SUBLOCADE, Bimzelx, ZORYVE.
Industry payments across FL — which companies pay providers there.
